ClinicalTrials.gg
RecruitingNCT07309575REGENERATIONUpdated Dec 30, 2025

Regional Versus General Anesthesia for Hip Fracture and Postoperative Oxygenation

An observational study in Hip-fracture, General Anaesthesia and Regional Anaesthesia, sponsored by University of Lisbon. Recruiting at 1 site in Portugal. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-12-30.

Sponsored by University of Lisbon · Observational

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
102
Ages
65 Years and older
Sex
All
01

Study summary

With this study, the investigators intend to measure oxygen saturation before and after hip surgery in the context of proximal femur fracture, comparing two types of anesthesia (general or spinal). The investigators also intend to study the effects of the two anesthetic techniques on sleep apnea, delirium, respiratory complications, and length of hospital stay.

This is an observational study, in which oxygen is measured at the fingertip with a sensor and a bracelet, without any intervention, inconvenience, or discomfort for the participant. Data will be collected on: respiratory complications, sleep apnea, delirium, length of hospital stay, and survival.

Data will be collected in the operating room and wards of Santa Maria Hospital, Lisbon, Portugal over a period of approximately 24 hours after the participant's operation. Information about participant's health and co-morbidities will be recorded.

There will be no implication for the participants' clinical care, since the study measurements will not be sent to the health professionals in charge. The operation, recovery, and treatments will not be influenced at any time by participation in the study.

Read the detailed description

Frailty, comorbidities, medication (anticoagulants and anti-platellet agents) as well as acute and chronic illnesses have an impact on the choice of anesthesia strategy for hip fracture surgery. The choice between general anesthesia (GA) and loco-regional, spinal anesthesia (SA) may have impact on the postoperative period. Despite previous retrospective studies on this topic, it remains uncertain that either is superior in terms of post-operative outcomes, including mortality, delirium and respiratory complications, with conflicting results in the literature.

Postoperative pulmonary complications (PPC) are amongst the commonest complications in geriatric hip fractures, reported to be around 12%. The elder population at Hospital de Santa Maria (Tertiary University Hospital Center) receives the most challenging cases, with pilot data from the past 3 years (2022-2024, n=927) revealing an average risk score for PPC of 32,1%.

Considering that low oxygen saturation is an independent risk factor and a strong predictor for PPC, the investigators seek to compare the oxygenation during the perioperative period between the different anesthesia regimens.

The study hypothesis is that the anesthesia regimen (GA vs SA) has an impact on the oxygenation index during the first 24 postoperative hours.

The secondary objectives are to compare the sleep apnea index between GA and SA, the incidence of PPC, delirium, mortality and the length of stay (LOS) in the PACU and until discharge from the hospital.

02

Conditions studied

  • Hip-fracture
  • General Anaesthesia
  • Regional Anaesthesia

Keywords

  • anaesthesia
  • hip femur fracture
  • postoperative pulmonary complications
  • oxygenation
  • sleep apnea
03

In context

Hip Fractures

842 studies on the registry are indexed under Hip Fractures; 165 are open to participants now.

This study's planned enrollment of 102 is below the median of 149 across 280 observational studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

University of Lisbon is the lead sponsor of 40 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Elder subjects with hip-fracture submitted to surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • hospital admission for hip fracture;
  • scheduled for hip fracture surgery;
  • age above 65 years, both genders;
  • capable of consent or consent by responsible person;

Exclusion criteria

Exclusion Criteria:

  • hip fracture during hospitalization (not present upon admission)
  • patient refusal to participate
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
102 participants (estimated)
Patient registry
No

Groups and cohorts

  • General anaesthesia

    Hip fracture surgery under general anaesthesia

  • Rregional anaesthesia

    Hip fracture surgery under regional anaesthesia

06

What researchers measure

Primary outcomes

  1. Oxygenation index (SpO2/FiO2 ratio)

    Oxygenation index (SpO2/FiO2 ratio) measured as the difference between oxygenation index on admission to the operating room and the mean SpO2 during the next 24 postoperative hours, compared between groups. Peripheral oxygen saturation measured continuously during the first postoperative day with the Konica Minolta PULSOX-DS5® device.

    Time frame: first postoperative day

Secondary outcomes

  1. Sleep Apnea index

    average dips of SpO2 per hour, (\>= 4%)

    Time frame: first postoperative day

  2. Length of stay in the Post-anestesia Care Unit

    Length of stay in the Post-anestesia Care Unit

    Time frame: after the surgery, at discharge from the Post-anestesia Care Unit

  3. Hospital Length of Stay (Days)

    Length of stay in the hospital from admission until discharge, in days

    Time frame: from hospital admission to hospital discharge, approximatelly 5 days

  4. postoperative pulmonary complications

    postoperative pulmonary complications defined as hypoxemia, respiratory failure, atelectasis, pneumothorax, respiratory infection.

    Time frame: during the first postoperative day

  5. Delirium

    Presence of delirium in the first postoperative day

    Time frame: during the first postoperative day

  6. in-Hospital mortality

    death from any cause during hospital stay, from hospital admission to discharge

    Time frame: From hospital admission to hospital discharge (or death), up to 3 months

07

Study locations

1 of 1 sites recruiting
  • Northern Lisbon Hospital Center
    Lisbon, Lisbon District 1635, Portugal
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — only anonymised data can be shared after publication and upon reasonable request

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.

Of 107 non-industry observational studies under Hip Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 65. This study's planned 13 months is below that.

Counting every sponsor, half of 124 studies reached it within 28 months; a quarter within 12 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2025
First posted
Dec 30, 2025
StartActual
Nov 27, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Dec 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07309575
Lead sponsor
University of Lisbon
Collaborators
Northern Lisbon Hospital Center
Responsible party
ANDRE DOS SANTOS ROCHA (Prof. MD PhD, University of Lisbon) — Principal investigator
First posted
Dec 30, 2025
Start date
Nov 27, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 30, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion